FSD2 anticorps (AA 221-320) (FITC)
-
- Antigène Voir toutes FSD2 Anticorps
- FSD2 (Fibronectin Type III and SPRY Domain Containing 2 (FSD2))
-
Épitope
- AA 221-320
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp FSD2 est conjugé à/à la FITC
-
Application
- Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))
- Homologie
- Human,Mouse,Rat,Dog,Cow,Sheep,Pig
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human FSD2
- Isotype
- IgG
- Top Product
- Discover our top product FSD2 Anticorps primaire
-
-
- Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- FSD2 (Fibronectin Type III and SPRY Domain Containing 2 (FSD2))
- Autre désignation
- FSD2 (FSD2 Produits)
- Synonymes
- anticorps SPRYD1, anticorps 9830160G03Rik, anticorps Spryd1, anticorps RGD1305167, anticorps fibronectin type III and SPRY domain containing 2, anticorps FSD2, anticorps Fsd2
- Sujet
-
Synonyms: Fibronectin type III and SPRY domain containing 2, Fibronectin type III and SPRY domain containing protein 2, RP11-127F21, SPRY domain containing 1, SPRY domain containing protein 1, SPRYD1,
Background: FSD2 is a 749 amino acid protein containing one B30.2/SPRY domain and two fibronectin type-III domains. The gene encoding FSD2 maps to human chromosome 15q25.2. Encoding more than 700 genes, chromosome 15 is made up of approximately 106 million base pairs and consists of about 3 % of the human genome. Angelman and Prader-Willi syndromes are associated with loss of function or deletion of genes in the 15q11-q13 region. In the case of Angelman syndrome, this loss is due to inactivity of the maternal 15q11-q13 encoded UBE3A gene in the brain by either chromosomal deletion or mutation. Prader-Willi syndrome, Tay-Sachs disease and Marfan syndrome are also associated with chromosome 15.
- ID gène
- 123722
-